Immediate Impact
1 by Nobel laureates 8 from Science/Nature 55 standout
Citing Papers
Fluorescent Probes for Disease Diagnosis
2024 Standout
Deciphering breast cancer: from biology to the clinic
2023 Standout
Works of Douglas Weckstein being referenced
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib
2015
Clinical and translational results of CALGB 40601: A neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer.
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Douglas Weckstein | 763 | 385 | 276 | 286 | 24 | 1.3k | |
| Hans Wildiers | 560 | 255 | 88 | 248 | 31 | 1.1k | |
| Steven Lau | 282 | 251 | 184 | 117 | 34 | 1.2k | |
| Leslie R. Ellis | 375 | 163 | 298 | 159 | 45 | 1.4k | |
| Sylvain Mareschal | 385 | 183 | 134 | 268 | 34 | 1.1k | |
| Blair Egerdie | 896 | 693 | 255 | 110 | 29 | 1.6k | |
| Jennifer Wilkinson | 236 | 272 | 346 | 458 | 35 | 1.3k | |
| Sukhbinder Dhesy‐Thind | 817 | 258 | 164 | 292 | 49 | 1.2k | |
| Hisataka Ogawa | 353 | 105 | 50 | 217 | 36 | 996 | |
| Keaton Jones | 673 | 257 | 54 | 181 | 28 | 1.6k | |
| V. Servent | 603 | 343 | 210 | 298 | 30 | 1.2k |
All Works
Loading papers...